STAT
‘Serious side effects’: FDA revokes emergency use authorization for hydroxychloroquine as COVID-19 treatment
The Food and Drug Administration on [June 15] said it had withdrawn an emergency approval for use of the malaria ...
COVID-19 vaccines unlikely to be ‘cure-alls’. That might not be such a bad thing
With a little luck and a lot of science, the world might in the not-too-distant future get vaccines against Covid-19 ...
Lancet medical journal retracts much-questioned COVID-19 ‘observational study’ that raised safety alarms about hydroxychloroquine
The Lancet, one of the world’s top medical journals, on [June 4] retracted an influential study that raised alarms about ...
Viewpoint: At-home test detects cervical cancer early. It should be available to all women
I’m a public health nurse who has spent a career studying ways to better test women for the human papillomavirus ...
COVID-19 hit the US as early as January, CDC analysis suggests
How early did local transmission of the SARS-CoV-2 virus begin in the United States? For the second time [recently], scientists ...
Adverse reactions in COVID-19 vaccine trial illustrates rocky road to developing therapies for diverse populations
Patients in clinical trials are usually faceless. But as the experimental Covid-19 vaccine being developed by Moderna Therapeutics has begun ...
Viewpoint: We can’t simply test our way out of the coronavirus pandemic
In response to calls for Covid-19 testing of the entire U.S. population, several large universities, and even some employers, have ...
Experimental Parkinson’s treatment draws ethics scrutiny with wealthy donor selected as first patient
A secretive experiment revealed [May 12], in which neurosurgeons transplanted brain cells into a patient with Parkinson’s disease, made medical ...
Pandemic could give a boost to remote-monitoring devices that keep patients out of the doctor’s office
It was a shift that began long before the pandemic: Tech companies, health providers, and patients alike were increasingly looking ...
‘This is what it feels like to be normal’: Experimental stem cell treatment shows promise against Parkinson’s
[Researchers planned] to carry out an experimental transplant surgery unprecedented in the annals of medicine: replacing the dysfunctional brain cells ...
There will be no vaccine widely available by fall (or anytime soon) even with a miracle breakthrough
Vaccines to prevent Covid-19 infection are hurtling through development at speeds never before seen. But mounting promises that some vaccine ...
What the porn industry can teach us about how to live safely with coronavirus
Since the late 1990s, when an outbreak of HIV infections threatened to shutter the multibillion-dollar industry, the mainstream porn community ...
Is this brain-controlled prosthetic arm—with the sensation of touch—the future of prosthetics?
[T]hree years ago, [electrician Rickard] Normark received a new kind of brain-controlled prosthetic that was surgically attached to the bone, ...
‘Impenetrable medical jargon’: Why retooling ClinicalTrials.gov should be a priority
Millions of people visit ClinicalTrials.gov each year to find a trial that they or a loved one might be eligible ...
Viewpoint: US failure to ‘study drugs more quickly’ means more people are dying from coronavirus
When medical historians look back at the Covid-19 pandemic, they will reckon with how the United States, with its vast ...
Using artificial intelligence to identify promising coronavirus treatments
Treating patients with the never-before-seen Covid-19 is forcing doctors to choose between two equally unpalatable options: try an unproven therapy ...
Gilead’s remdesivir offers little benefit for coronavirus patients in early trial
The antiviral medicine remdesivir from Gilead Sciences failed to speed the improvement of patients with Covid-19 or prevent them from ...
When will experimental coronavirus drugs will be ready for the clinic?
Is there hope that something will be available soon to help us fight this virus, known as SARS-CoV-2? Here’s a ...
Dark side of CRISPR: Rogue scientists could design something nastier than the coronavirus
When we’ve emerged on the other side of the pandemic, Covid-19 will someday make a good story. But I worry ...
Dealing with ‘confusing directives’, US doctors seek coronavirus advice from Chinese counterparts
Now, fed up with what they see as inadequate and confusing directives from public health authorities, many physicians are trying ...
CRISPR pioneer Jennifer Doudna turns lab into coronavirus test center
A team of academic and industry researchers led by Jennifer Doudna, the researcher best known for her role in the ...
Viewpoint: We’re making big decisions on the coronavirus without solid data
At a time when everyone needs better information, from disease modelers and governments to people quarantined or just social distancing, ...
Coronavirus immunotherapy could arrive by early summer. Is ‘record time’ fast enough?
Blood-plasma-based cures aren’t just the stuff of movies. There’s plenty of science to back the idea that blood products from ...
Some countries have done a much better job fighting the coronavirus. Here’s what worked.
With Europe and the United States locked in deadly battle with the coronavirus that causes Covid-19, a number of countries ...
Hunting for DNA signatures in blood could offer early warning system for cancer
The many companies developing liquid biopsies to try to detect cancer early have so far largely mined the blood in ...
Viewpoint: Promise of genomics and precision medicine a ‘wave of hype without substance’
An undeclared civil war is breaking out in biomedicine. On one side is precision medicine, with its emphasis on tailoring treatments ...
Viewpoint: Embracing biosimilars will drive down prices, increase access to drugs
The biosimilar category holds incredible promise, and the market for these products is on an upward trajectory. But it’s been ...
